Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta.

Exposure of isolated arteries to oxidatively modified low density lipoprotein (LDL) has been reported to suppress endothelium-dependent relaxation (EDR). To determine whether lipid degradation products in oxidized LDL contribute to impaired relaxation, we have tested the responsiveness of isolated rabbit aortas to endothelium-dependent relaxants (acetylcholine, ATP, and calcium ionophore A23187) and nitroglycerin before and after 2-hour incubations with selected lipids and LDL preparations. Concentrations (10 microM) of lecithin, phosphatidylserine, lysophosphatidylserine, sphingomyelin, phosphatidic acid, palmitate, arachidonate, and auto-oxidized arachidonate had no effect on EDR. Concentrations (10 microM) of lysolecithin, lyso-platelet activating factor, and sphingosine significantly suppressed endothelium-dependent relaxation. Native LDL (100 micrograms/ml incubation buffer) containing only small amounts of lysophosphatidylcholine exerted no effect on EDR. In contrast, LDL preparations oxidatively modified by exposure to cultured endothelial cells or copper inhibited EDR. When modified LDL was depleted of its lysolecithin by treatment with a selective phospholipase B (lysolecithinase), the inhibitory effects were attenuated. In contrast, native LDL accumulating lysolecithin under the influence of a phospholipase A2 (lecithinase) exerted inhibitory effects mimicking those of oxidized LDL. Lipids and lipoproteins had no effect on the responsiveness to nitroglycerin, an endothelium-independent vasodilator. We conclude that lysolecithin in oxidatively modified LDL contributes importantly to its vasomotor effects.

[1]  G. Rubanyi.  Endothelium‐derived relaxing and contracting factors , 1991, Journal of cellular biochemistry.

[2]  T. Nikkari,et al.  Atherosclerosis and biochemical composition of coronary arteries in Finnish men. Comparison of two populations with different incidences of coronary heart disease. , 1987, Atherosclerosis.

[3]  T. Aoyama,et al.  Lipoproteins are inhibitors of endothelium-dependent relaxation of rabbit aorta. , 1990, The American journal of physiology.

[4]  D. Steinberg,et al.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Hirata,et al.  Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. , 1990, Biochemical and biophysical research communications.

[6]  H. Pownall,et al.  Transport of biological lipophiles: Effect of lipophile structure , 1983 .

[7]  J. Vane,et al.  Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.

[8]  H. C. Stary.  Macrophage Foam Cells in the Coronary Artery Intima of Human Infants a , 1985, Annals of the New York Academy of Sciences.

[9]  D. Steinberg,et al.  Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Robert A. Lewis,et al.  Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. , 1990, The New England journal of medicine.

[11]  K. Kugiyama,et al.  Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins , 1990, Nature.

[12]  J. Knight,et al.  Peroxidation of linolenic acid--catalysis by transition metal ions. , 1990, Annals of clinical and laboratory science.

[13]  G. Vidaver,et al.  Evidence that lysolecithin is an important causal agent of atherosclerosis. , 1985, Journal of theoretical biology.

[14]  J L Witztum,et al.  Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. D. Henry,et al.  Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. , 1987, The Journal of clinical investigation.

[16]  R. Cohen,et al.  Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. , 1990, The Journal of clinical investigation.

[17]  R Busse,et al.  Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[18]  D. Steinberg,et al.  Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. Bruckdorfer,et al.  Inhibition of endothelium-dependent relaxation by oxidized low-density lipoproteins. , 1990, Biochemical Society transactions.

[20]  D. Morel,et al.  Endothelial and Smooth Muscle Cells Alter Low Density Lipoprotein In Vitro by Free Radical Oxidation , 1984, Arteriosclerosis.

[21]  J. Esko,et al.  Biosynthesis of phosphatidylcholine from serum phospholipids in Chinese hamster ovary cells deprived of choline. , 1983, The Journal of biological chemistry.

[22]  T. Tomita,et al.  Rapid and reversible inhibition by low density lipoprotein of the endothelium-dependent relaxation to hemostatic substances in porcine coronary arteries. Heat and acid labile factors in low density lipoprotein mediate the inhibition. , 1990, Circulation research.

[23]  J. Falck,et al.  Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolites. , 1989, The Journal of biological chemistry.

[24]  R. Ordway,et al.  Direct regulation of ion channels by fatty acids , 1991, Trends in Neurosciences.